PRMD — Primemd Income Statement

0.000.00%

Last trade - 00:00

HealthcareHighly SpeculativeMicro Cap

Annual income statement for Primemd, fiscal year end - March 31st, USD millions except per share, conversion factor applied.

	2004 March 31st	2005 March 31st	2006 March 31st	2007 March 31st	2008 March 31st
Period Length:	12 M	12 M	12 M	12 M	12 M
Source:	10KSB	10KSB	10KSB	10KSB	10-K/A
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Revenue
Total Revenue	0.058	0.039	0.053	0.049	0.068
Selling / General / Administrative Expenses
Depreciation and Amortization
Other Operating Expenses
Total Operating Expenses	0.233	0.239	0.218	0.265	0.175
Operating Profit	-0.175	-0.2	-0.165	-0.216	-0.107
Gain / Loss on Sale of Assets
Total Net Non Operating Interest Income / Expense
Other Net Non Operating Costs
Net Income Before Taxes	-0.149	-0.159	-0.156	0.195	-0.101
Provision for Income Taxes
Net Income After Taxes	-0.149	-0.159	-0.156	0.195	-0.101
Net Income Before Extraordinary Items
Net Income	-0.149	-0.159	-0.156	0.195	-0.101
Income Available to Common Shareholders Excluding Extraordinary Items
Income Available to Common Shareholders Including Extraordinary Items
Dilution Adjustment
Diluted Net Income	-0.149	-0.159	-0.156	0.195	-0.101
Diluted Weighted Average Shares
Basic EPS Including Extraordinary Items
Diluted EPS Including Extraordinary Items
Diluted EPS Excluding Extraordinary Items
Normalised Income Before Taxes
Normalised Income After Taxes
Normalised Income Available to Common Shareholders
Diluted Normalised EPS	-0.048	-0.052	-0.051	0.063	-0.033
Dividends per Share